Home | All secondary_outcomes

[RDF data]
Secondary Outcomes #100281

Resource URI: http://static.linkedct.org/resource/secondary_outcomes/100281
PropertyValue
rdfs:label Secondary Outcomes #100281
linkedct:measure Safety (Incidence of adverse events, Presence of human anti-murine antibodies after ertumaxomab infusion, Assessment of heart function, Cytokine production)
linkedct:safety_issue Yes
is linkedct:secondary_outcomes of <http://static.linkedct.org/resource/trials/NCT00522457>
linkedct:secondary_outcomes_id 100281 (xsd:int)
linkedct:time_frame patients are monitored for 6 months
rdf:type linkedct:secondary_outcomes